HIV-1 is dependent upon cellular co-factors to mediate its replication cycle in CD4(+) T cells and macrophages, the two major cell types infected by the virus in vivo. One critical co-factor is Cyclin T1, a subunit of a general RNA polymerase II elongation factor known as P-TEFb. Cyclin T1 is targeted directly by the viral Tat protein to activate proviral transcription. Cyclin T1 is up-regulated when resting CD4(+) T cells are activated and during macrophage differentiation or activation, conditions that are also necessary for high levels of HIV-1 replication. Because Cyclin T1 is a subunit of a transcription factor, the up-regulation of Cyclin T1 in these cells results in the induction of cellular genes, some of which might be HIV-1 co-fac...
<div><p>Despite the success of cART, greater than 50% of HIV infected people develop cognitive and m...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...
AbstractPrevious work has shown that C/EBP sites and C/EBP transcriptional activators are necessary ...
Abstract Background P-TEFb, a general RNA polymerase II elongation factor, is composed of CDK9 (cycl...
Abstract Background The regulatory cyclin, Cyclin T1 (CycT1), is a host factor essential for HIV-1 r...
Human immunodeficiency virus type 1 (HIV-1)-encoded Tat provides transcriptional activation critical...
The human positive transcription elongation factor P-TEFb is composed of two subunits, cyclin T1 (hC...
Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor def...
The molecular mechanisms that regulate the function of the immune system and human immunodeficiency ...
Thirteen years ago, human cyclin T1 was identified as part of the positive transcription elongation ...
Macrophages are a heterogeneous cell population strongly influenced by differentiation stimuli that ...
Human immunodeficiency virus-1 (HIV-1) exploits a number of host cellular factors for successful sur...
Abstract Background HIV-1 Tat activates RNA Polymerase II (RNAP II) elongation of the integrated pro...
Human immunodeficiency virus, type 1 (HIV-1), Tat protein activates viral gene expression through pr...
Human immunodeficiency virus, type 1 (HIV-1), Tat protein activates viral gene expression through pr...
<div><p>Despite the success of cART, greater than 50% of HIV infected people develop cognitive and m...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...
AbstractPrevious work has shown that C/EBP sites and C/EBP transcriptional activators are necessary ...
Abstract Background P-TEFb, a general RNA polymerase II elongation factor, is composed of CDK9 (cycl...
Abstract Background The regulatory cyclin, Cyclin T1 (CycT1), is a host factor essential for HIV-1 r...
Human immunodeficiency virus type 1 (HIV-1)-encoded Tat provides transcriptional activation critical...
The human positive transcription elongation factor P-TEFb is composed of two subunits, cyclin T1 (hC...
Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor def...
The molecular mechanisms that regulate the function of the immune system and human immunodeficiency ...
Thirteen years ago, human cyclin T1 was identified as part of the positive transcription elongation ...
Macrophages are a heterogeneous cell population strongly influenced by differentiation stimuli that ...
Human immunodeficiency virus-1 (HIV-1) exploits a number of host cellular factors for successful sur...
Abstract Background HIV-1 Tat activates RNA Polymerase II (RNAP II) elongation of the integrated pro...
Human immunodeficiency virus, type 1 (HIV-1), Tat protein activates viral gene expression through pr...
Human immunodeficiency virus, type 1 (HIV-1), Tat protein activates viral gene expression through pr...
<div><p>Despite the success of cART, greater than 50% of HIV infected people develop cognitive and m...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...
AbstractPrevious work has shown that C/EBP sites and C/EBP transcriptional activators are necessary ...